First Time Loading...

Soligenix Inc
NASDAQ:SNGX

Watchlist Manager
Soligenix Inc Logo
Soligenix Inc
NASDAQ:SNGX
Watchlist
Price: 0.427 USD 11.49%
Updated: Apr 26, 2024

Intrinsic Value

SNGX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. [ Read More ]

The intrinsic value of one SNGX stock under the Base Case scenario is 1.382 USD. Compared to the current market price of 0.427 USD, Soligenix Inc is Undervalued by 69%.

Key Points:
SNGX Intrinsic Value
Base Case
1.382 USD
Undervaluation 69%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Soligenix Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling SNGX stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Soligenix Inc

Provide an overview of the primary business activities
of Soligenix Inc.

What unique competitive advantages
does Soligenix Inc hold over its rivals?

What risks and challenges
does Soligenix Inc face in the near future?

Has there been any significant insider trading activity
in Soligenix Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Soligenix Inc.

Provide P/S
for Soligenix Inc.

Provide P/E
for Soligenix Inc.

Provide P/OCF
for Soligenix Inc.

Provide P/FCFE
for Soligenix Inc.

Provide P/B
for Soligenix Inc.

Provide EV/S
for Soligenix Inc.

Provide EV/GP
for Soligenix Inc.

Provide EV/EBITDA
for Soligenix Inc.

Provide EV/EBIT
for Soligenix Inc.

Provide EV/OCF
for Soligenix Inc.

Provide EV/FCFF
for Soligenix Inc.

Provide EV/IC
for Soligenix Inc.

Show me price targets
for Soligenix Inc made by professional analysts.

What are the Revenue projections
for Soligenix Inc?

How accurate were the past Revenue estimates
for Soligenix Inc?

What are the Net Income projections
for Soligenix Inc?

How accurate were the past Net Income estimates
for Soligenix Inc?

What are the EPS projections
for Soligenix Inc?

How accurate were the past EPS estimates
for Soligenix Inc?

What are the EBIT projections
for Soligenix Inc?

How accurate were the past EBIT estimates
for Soligenix Inc?

Compare the revenue forecasts
for Soligenix Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Soligenix Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Soligenix Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Soligenix Inc compared to its peers.

Compare the P/E ratios
of Soligenix Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Soligenix Inc with its peers.

Analyze the financial leverage
of Soligenix Inc compared to its main competitors.

Show all profitability ratios
for Soligenix Inc.

Provide ROE
for Soligenix Inc.

Provide ROA
for Soligenix Inc.

Provide ROIC
for Soligenix Inc.

Provide ROCE
for Soligenix Inc.

Provide Gross Margin
for Soligenix Inc.

Provide Operating Margin
for Soligenix Inc.

Provide Net Margin
for Soligenix Inc.

Provide FCF Margin
for Soligenix Inc.

Show all solvency ratios
for Soligenix Inc.

Provide D/E Ratio
for Soligenix Inc.

Provide D/A Ratio
for Soligenix Inc.

Provide Interest Coverage Ratio
for Soligenix Inc.

Provide Altman Z-Score Ratio
for Soligenix Inc.

Provide Quick Ratio
for Soligenix Inc.

Provide Current Ratio
for Soligenix Inc.

Provide Cash Ratio
for Soligenix Inc.

What is the historical Revenue growth
over the last 5 years for Soligenix Inc?

What is the historical Net Income growth
over the last 5 years for Soligenix Inc?

What is the current Free Cash Flow
of Soligenix Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Soligenix Inc.

Financials

Balance Sheet Decomposition
Soligenix Inc

Current Assets 9.5m
Cash & Short-Term Investments 8.4m
Receivables 195.2k
Other Current Assets 866k
Non-Current Assets 290k
PP&E 241.8k
Other Non-Current Assets 48.3k
Current Liabilities 6.2m
Accounts Payable 1.1m
Accrued Liabilities 2.8m
Other Current Liabilities 2.3m
Non-Current Liabilities 1.1m
Long-Term Debt 1m
Other Non-Current Liabilities 111.9k
Efficiency

Earnings Waterfall
Soligenix Inc

Revenue
839.4k USD
Cost of Revenue
-742.1k USD
Gross Profit
97.3k USD
Operating Expenses
-7.8m USD
Operating Income
-7.7m USD
Other Expenses
1.6m USD
Net Income
-6.1m USD

Free Cash Flow Analysis
Soligenix Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

SNGX Profitability Score
Profitability Due Diligence

Soligenix Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional ROIC
Positive Gross Profit
Positive Revenue Growth Forecast
32/100
Profitability
Score

Soligenix Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

SNGX Solvency Score
Solvency Due Diligence

Soligenix Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Short-Term Solvency
Long-Term Solvency
42/100
Solvency
Score

Soligenix Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SNGX Price Targets Summary
Soligenix Inc

Wall Street analysts forecast SNGX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SNGX is 3.443 USD with a low forecast of 3.03 USD and a high forecast of 3.938 USD.

Lowest
Price Target
3.03 USD
610% Upside
Average
Price Target
3.443 USD
706% Upside
Highest
Price Target
3.938 USD
822% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

SNGX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

SNGX Price
Soligenix Inc

1M 1M
-28%
6M 6M
-16%
1Y 1Y
-67%
3Y 3Y
-98%
5Y 5Y
-96%
10Y 10Y
-100%
Annual Price Range
0.427
52w Low
0.383
52w High
2.28
Price Metrics
Average Annual Return 4.39%
Standard Deviation of Annual Returns 66.87%
Max Drawdown -99%
Shares Statistics
Market Capitalization 4.4m USD
Shares Outstanding 10 524 400
Percentage of Shares Shorted 1.1%

SNGX Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Soligenix Inc Logo
Soligenix Inc

Country

United States of America

Industry

Biotechnology

Market Cap

4.4m USD

Dividend Yield

0%

Description

Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. The company is headquartered in Princeton, New Jersey and currently employs 13 full-time employees. The firm is focused on developing products to treat rare diseases. The firm operates through two segments: Specialized BioTherapeutics and Public Health Solutions. Specialized BioTherapeutics segments includes developing of HyBryte (SGX301 or synthetic hypericin) a photodynamic therapy for the treatment of cutaneous T-cell lymphoma (CTCL). Public Health Solutions segment includes RiVax to protect against exposure to ricin toxin vaccine candidate and SGX943 therapeutic candidate for antibiotic resistant and infectious disease. The firm's Development programs include innate defense regulator (IDR) technology, dusquetide (SGX942) for the treatment of inflammatory diseases, oral mucositis in head and neck cancer, and oral beclomethasone 17,21-dipropionate (BDP) for the prevention/treatment of gastrointestinal (GI) disorders including pediatric Crohn's disease (SGX203).

Contact

NEW JERSEY
Princeton
29 Emmons Dr Ste B10
+16095388200.0
https://www.soligenix.com/

IPO

1994-04-04

Employees

13

Officers

Chairman of the Board of Directors, CEO & President
Dr. Christopher J. Schaber Ph.D.
Senior VP, CFO & Corporate Secretary
Mr. Jonathan L. Guarino CPA, CGMA
Senior VP & Chief Scientific Officer
Dr. Oreola Donini Ph.D.
Senior VP & Chief Medical Officer
Dr. Richard C. Straube M.D., MSc.

See Also

Discover More
What is the Intrinsic Value of one SNGX stock?

The intrinsic value of one SNGX stock under the Base Case scenario is 1.382 USD.

Is SNGX stock undervalued or overvalued?

Compared to the current market price of 0.427 USD, Soligenix Inc is Undervalued by 69%.